The deal builds on staff access to a custom version of ChatGPT to help scientists identify drug targets faster rather than replace workers.#Danish #drugmaker #Novo #Nordisk #taps #OpenAI #drug #RampD
Danish drugmaker Novo Nordisk taps OpenAI in drug R&D
